Defense research spending up, NIH bill fails
On Tuesday (Nov. 13) President Bush linkurl:signed;http://chronicle.com/subscribe/login?url=http%3A%2F%2Fchronicle.com%2Fdaily%2F2007%2F11%2F708n.htm a defense bill linkurl:(HR 3222);http://frwebgate.access.gpo.gov/cgibin/getdoc.cgi?
On Tuesday (Nov. 13) President Bush linkurl:signed;http://chronicle.com/subscribe/login?url=http%3A%2F%2Fchronicle.com%2Fdaily%2F2007%2F11%2F708n.htm a defense bill linkurl:(HR 3222);http://frwebgate.access.gpo.gov/cgibin/getdoc.cgi?dbname=110_cong_bills&docid=f:h3222enr.txt.pdf that ups the 2008 Pentagon budget by $40 billion from last year and increases Pentagon-funded basic research programs by about $81.2 million, according to a spokesperson for the bill's sponsor, Representative John Murtha (R-PA).
HR 3222 increases funding for peer-reviewed breast cancer research programs by about $10.5 million over last year to $138 million. It also provides $80 million for peer-reviewed prostate cancer research and $10 million for ovarian cancer research, maintaining last year's funding of these programs.
Bush signed the defense bill the same day that he linkurl:vetoed;http://www.the-scientist.com/news/home/53858/ the Labor, Health and Human Services, and Education linkurl:bill;http://www.the-scientist.com/blog/display/53852/ that sought to increase the budgets of the departments of Labor and Education as well as that of the NIH.
Last night (Nov. 15) the House of Representatives failed to override the Bush veto, falling just two votes short of the two-thirds vote necessary.
Funding for applied research in the defense bill actually drops by about $186.6 million from last year's defense budget.
November 17, 2007
In my opinion,as regards NHI bill the central role would be played by destination of such as money. As far as physicians are thinking that ALL men may be involved, e.g., by prostate cancer, money is uslessly loss.Read: Stagnaro Sergio. Bed-Side Prostate Cancer Detecting, even in early stages (?Real Risk? of Cancer): BMC Family Practice, 6:24 doi:10.1186/1471-2296-6-24 http://www.biomedcentral.com/1471-2296/6/24/comments#202466